SEARCH

SEARCH BY CITATION

References

  • 1
    Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2004; 4(Suppl 10): 160163.
  • 2
    Avery RK. Immunizations in adult immunocompromised patients: Which to use and which to avoid. Cleve Clin J Med 2001; 68: 337348.
  • 3
    Ballout A, Goffin E, Yombi JC, Vandercam B. Vaccinations for adult solid organ transplant recipient: Current recommendations. Transplant Proc 2005; 37: 28262827.
  • 4
    Burroughs M, Moscona A. Immunization of pediatric solid organ transplant candidates and recipients. Clin Infect Dis 2000; 30: 857869.
  • 5
    Campbell AL, Herold BC. Immunization of pediatric solid-organ transplantation candidates: Immunizations in transplant candidates. Pediatr Transplant 2005; 9: 652661.
  • 6
    Casswall TH, Fischler B. Vaccination of the immunocompromised child. Expert Rev Vaccines 2005; 4: 725738.
  • 7
    Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for adult solid-organ transplant recipients: Current recommendations and protocols. Clin Microbiol Rev 2003; 16: 357364.
  • 8
    Lopez MJ, Thomas S. Immunization of children after solid organ transplantation. Pediatr Clin North Am 2003; 50: 14351449.
  • 9
    Molrine DC, Hibberd PL. Vaccines for transplant recipients. Infect Dis Clin North Am 2001; 15: 273305.
  • 10
    Pirofski LA, Casadevall A. Use of licensed vaccines for active immunization of the immunocompromised host. Clin Microbiol Rev 1998; 11: 126.
  • 11
    Verma A, Wade JJ. Immunization issues before and after solid organ transplantation in children. Pediatr Transplant 2006; 10: 536548.
  • 12
    Kotton CN, Ryan ET, Fishman JA. Prevention of infection in adult travelers after solid organ transplantation. Am J Transplant 2005; 5: 814.
  • 13
    Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56(RR-2): 124.
  • 14
    Oxman MN, Levin MJ, Johnson GR et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 22712284.
  • 15
    American Academy of Pediatrics Committee on Infectious Diseases. Prevention of rotavirus disease: Guidelines for use of rotavirus vaccine. Pediatrics 2007; 119: 171182.
  • 16
    Broder KR, Cortese MM, Iskander JK et al. Preventing tetanus, diphtheria, and pertussis among adolescents: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55(RR-3): 134.
  • 17
    Kretsinger K, Broder KR, Cortese MM et al. Preventing tetanus, diphtheria, and pertussis among adults: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 2006; 55(RR-17): 137.
  • 18
    Bauer T, Gunther M, Bienzle U, Neuhaus R, Jilg W. Vaccination against hepatitis B in liver transplant recipients: Pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells. Liver Transpl 2007; 13: 434442.
  • 19
    Gunther M, Neuhaus R, Bauer T, Jilg W, Holtz JA, Bienzle U. Immunization with an adjuvant hepatitis B vaccine in liver transplant recipients: Antibody decline and booster vaccination with conventional vaccine. Liver Transpl 2006; 12: 316319.
  • 20
    Poland GA, Poterucha JJ. Hepatitis B immunization after liver transplantation: What is the answer Liver Transpl 2005; 11: 11811183.
  • 21
    Rosenau J, Hooman N, Hadem J et al. Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation. Liver Transpl 2007; 13: 367373.
  • 22
    Samuel D, Shouval D. The questionable role of immunization against hepatitis B in HBV infected liver transplant patients. J Hepatol 2005; 43: 203206.
  • 23
    Shouval D. Adoptive transfer of immunity to HBV in liver transplant patients: A step forward toward the proof of concept for therapeutic vaccination or a transient immunologic phenomenon Liver Transpl 2007; 13: 1417.
  • 24
    Blumberg EA, Brozena SC, Stutman P, Wood D, Phan HM, Musher DM. Immunogenicity of pneumococcal vaccine in heart transplant recipients. Clin Infect Dis 2001; 32: 307310.
  • 25
    McCashland TM, Preheim LC, Gentry MJ. Pneumococcal vaccine response in cirrhosis and liver transplantation. J Infect Dis 2000; 181: 757760.
  • 26
    Sarmiento E, Rodriguez-Hernandez C, Rodriguez-Molina J et al. Impaired anti-pneumococcal polysaccharide antibody production and invasive pneumococcal infection following heart transplantation. Int Immunopharmacol 2006; 6: 20272030.
  • 27
    Blumberg EA, Albano C, Pruett T et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996; 22: 295302.
  • 28
    Kumar D, Welsh B, Siegal D, Chen MH, Humar A. Immunogenicity of pneumococcal vaccine in renal transplant recipients–three year follow-up of a randomized trial. Am J Transplant 2007; 7: 633638.
  • 29
    Lin PL, Michaels MG, Green M et al. Safety and immunogenicity of the American Academy of Pediatrics–recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients. Pediatrics 2005; 116: 160167.
  • 30
    Henning KJ, White MH, Sepkowitz KA, Armstrong D. A national survey of immunization practices following allogeneic bone marrow transplantation. JAMA 1997; 277: 11481151.
  • 31
    Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 2000; 49(RR-10): 1125, CE121–127.
  • 32
    Blumberg EA, Fitzpatrick J, Stutman PC, Hayden FG, Brozena SC. Safety of influenza vaccine in heart transplant recipients. J Heart Lung Transplant 1998; 17: 10751080.
  • 33
    Burbach G, Bienzle U, Stark K et al. Influenza vaccination in liver transplant recipients. Transplantation 1999; 67: 753755.
  • 34
    Kimball P, Verbeke S, Flattery M, Rhodes C, Tolman D. Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients. Transplantation 2000; 69: 24492451.
  • 35
    Lawal A, Basler C, Branch A, Gutierrez J, Schwartz M, Schiano TD. Influenza vaccination in orthotopic liver transplant recipients: Absence of post administration ALT elevation. Am J Transplant 2004; 4: 18051809.
  • 36
    Magnani G, Falchetti E, Pollini G et al. Safety and efficacy of two types of influenza vaccination in heart transplant recipients: A prospective randomised controlled study. J Heart Lung Transplant 2005; 24: 588592.
  • 37
    White-Williams C, Brown R, Kirklin J et al. Improving clinical practice: Should we give influenza vaccinations to heart transplant patients J Heart Lung Transplant 2006; 25: 320323.
  • 38
    Halpern SD, Asch DA, Shaked A, Stock P, Blumberg EA. Inadequate hepatitis B vaccination and post-exposure evaluation among transplant surgeons: Prevalence, correlates, and implications. Ann Surg 2006; 244: 305309.
  • 39
    Human papillomavirus infection. Am J Transplant 2004; 4(Suppl 10): 95100.
  • 40
    Other herpesviruses: HHV-6, HHV-7, HHV-8, HSV-1 and 2, VZV. Am J Transplant 2004; 4(Suppl 10): 6671.
  • 41
    ACIP provisional recommendations for the use of zoster vaccine. Available from: http://www.cdc.gov/nip/recs/provisional_recs/zoster-11-20-06.pdf. Accessed 22 April, 2007.
  • 42
    U.S. Food and Drug Administration. Product Approval Information—Licensing Action: Zostavax. Available from: http://www.fda.gov/Cber/label/zosmer052506LB.htm. Accessed 22 April, 2007.
  • 43
    Weinberg A, Horslen SP, Kaufman SS et al. Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant 2006; 6: 565568.
  • 44
    Khan S, Erlichman J, Rand EB. Live virus immunization after orthotopic liver transplantation. Pediatr Transplant 2006; 10: 7882.
  • 45
    Kraft JN, Shaw JC. Varicella infection caused by Oka strain vaccine in a heart transplant recipient. Arch Dermatol 2006; 142: 943945.
  • 46
    Levitsky J, Te HS, Faust TW, Cohen SM. Varicella infection following varicella vaccination in a liver transplant recipient. Am J Transplant 2002; 2: 880882.
  • 47
    Ner Z, Ross LA, Horn MV et al. Bordetella bronchiseptica infection in pediatric lung transplant recipients. Pediatr Transplant 2003; 7: 413417.
  • 48
    Viral hepatitis guidelines in hemodialysis and transplantation. Am J Transplant 2004; 4(Suppl 10): 7282.
  • 49
    Chung RT, Feng S, Delmonico FL. Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor. Am J Transplant 2001; 1: 185191.
  • 50
    Bienzle U, Gunther M, Neuhaus R et al. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology 2003; 38: 811819.
  • 51
    Centers for Disease Control and Prevention National Immunization Program. Meningococcal disease and meningococcal vaccines. Available from: http://www.cdc.gov/nip/vaccine/mening/mening_fs.htm. Accessed 22 April, 2007.
  • 52
    Recommendations of the Advisory Committee on Immunization Practices (ACIP). Preventing pneumococcal disease among infants and young children. MMWR Recomm Rep 2000; 49(RR-9): 135.
  • 53
    Kumar D, Rotstein C, Miyata G, Arlen D, Humar A. Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients. J Infect Dis 2003; 187: 16391645.
  • 54
    Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep 1999; 48: 1007.
  • 55
    Parashar UD, Alexander JP, Glass RI. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55(RR-12): 113.
  • 56
    Gasink LB, Wurcell AG, Kotloff RM, Lautenbach E, Blumberg EA. Low prevalence of prior streptococcus pneumoniae vaccination among potential lung transplant candidates. Chest 2006; 130: 218221.
  • 57
    Goldfarb NS, Avery RK, Goormastic M et al. Hypogammaglobulinemia in lung transplant recipients. Transplantation 2001; 71: 242246.
  • 58
    Grekas D, Alivanis P, Kiriazopoulou V et al. Influenza vaccination on renal transplant patients is safe and serologically effective. Int J Clin Pharmacol Ther Toxicol 1993; 31: 553556.
  • 59
    Kobashigawa JA, Warner-Stevenson L, Johnson BL et al. Influenza vaccine does not cause rejection after cardiac transplantation. Transplant Proc 1993; 25: 27382739.
  • 60
    Murray SB, Skull SA. Poor health care worker vaccination coverage and knowledge of vaccination recommendations in a tertiary Australia hospital. Aust N Z J Public Health 2002; 26: 6568.